Filtered By:
Specialty: Nuclear Medicine
Countries: Canada Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Assessing the pharmacokinetics and metabolism of 18FLMI1195 in clinical imaging populations
Conclusions: These preliminary results suggest notable differences in the clearance and metabolic profiles of [18F]LMI1195 dependent on the given disease pathology. Radiotracer parent fraction can be equally measured by column-switching HPLC or SPE. These findings offer an important consideration for estimation of myocardial sympathetic nerve density using [18F]LMI1195 in patients suffering from cardiovascular disease. Support: Heart & Stroke Foundation of Canada/CANet ERLI (Rotstein) References: [1] Zelt, J. G. E. et al. J. Nucl. Cardiol. 2019, 26 (6), 2151-2153. [2] Sinusas, A. J. et al. J. Nucl. Med. 2014, 55 (9), 1...
Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Mair, B., Al Haddad, R., Zelt, J., Dinelle, K., Quigley, S., Beanlands, R., DeKemp, R., Rotstein, B. Tags: Clinical Science (Poster Session) Source Type: research
